Abstract
THE purpose of this communication is to report the excretion of grossly increased amounts of xanthurenic acid in the urine of women taking a combination of a progestogen and an oestrogen for contraceptive purposes, following a tryptophan load.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Coppini, D., Benassi, C. A., and Montorsi, M., Clin. Chem., 5, 391 (1959).
Wachstein, M., and Gudaitis, A., J. Lab. Clin. Med., 42, 98 (1953).
Wachstein, M., and Lobel, S., Proc. Soc. Exp. Biol. and Med., 86, 624 (1954).
Brown, R. R., Thornton, M. J., and Price, J. M., J. Clin. Invest., 40, 617 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ROSE, D. Excretion of Xanthurenic Acid in the Urine of Women taking Progestogen-Oestrogen Preparations. Nature 210, 196–197 (1966). https://doi.org/10.1038/210196a0
Issue date:
DOI: https://doi.org/10.1038/210196a0
This article is cited by
-
Lower levels of the neuroprotective tryptophan metabolite, kynurenic acid, in users of estrogen contraceptives
Scientific Reports (2023)
-
Stoffwechseluntersuchungen unter Einnahme oraler Kontrazeptiva
Zeitschrift für Ernährungswissenschaft (1978)
-
In vitro-Aktivierung der Serumtransaminasen durch Pyridoxal-5?-phosphat
Klinische Wochenschrift (1970)
-
Oral Contraceptives and Plasma Amino-acids
Nature (1969)
-
Metabolism of Tryptophan to Nicotinic Acid Derivatives by Women taking Oestrogen–Progestogen Preparations
Nature (1968)
